Related Experiment Video
Updated: Dec 13, 2025
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
2.0K
Anticoagulation following mitral valve repair
Tessa M F Watt1, Shannon L Murray1, Alexander A Brescia1
1Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.
Journal of Cardiac Surgery
|August 3, 2020
Summary
Warfarin anticoagulation after mitral valve repair reduced bleeding and thromboembolic complications. Postoperative warfarin use also improved long-term survival, suggesting its safety and efficacy in preventing complications.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Anticoagulation guidelines after mitral valve repair are not well-established.
- The study addresses the controversy surrounding postoperative anticoagulation.
- Investigates the impact of warfarin on patient outcomes post-mitral valve repair.
Purpose of the Study:
- To evaluate the association between postoperative warfarin use and complications after mitral valve repair.
- To assess the impact on bleeding, thromboembolic events, readmission, and mortality.
- To determine the safety and efficacy of warfarin in this patient population.
Main Methods:
- Retrospective study of 1097 patients undergoing elective mitral valve repair.
- Comparison between 775 patients on warfarin (INR goal 2.5) and 322 not anticoagulated.
- Univariate and multiple logistic regression analyses were used to assess outcomes.
Main Results:
- Warfarin use significantly reduced the composite of bleeding and thromboembolic complications (OR 0.29, P=.003).
- No significant difference in 30-day or 6-month mortality or readmission rates.
- Superior long-term survival in the warfarin group (10-year: 92% vs 85%, P<.001).
Conclusions:
- Postoperative warfarin use is associated with reduced complications and improved long-term survival after mitral valve repair.
- Warfarin appears to be a safe and effective option for preventing complications.
- A prospective randomized clinical trial is recommended to confirm these findings.
More Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
152
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
152
01:25Mitral Regurgitation III: Medical Management
173
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
173
01:22Mitral Valve Prolapse II: Assessment and Management
233
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
233
01:28Mitral Regurgitation IV: Nursing Management
225
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
225
01:27Mitral Stenosis IV: Nursing Management
189
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
189
01:22Mitral Stenosis I: Introduction
232
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
232